Navigation Links
Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011
Date:10/24/2011

NEW YORK, Oct. 24, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 – Volume I 2011

http://www.reportlinker.com/p0568107/Gastric-Cancer---Global-Drug-Forecasts-and-Treatment-Analysis-to-2020-–-Volume-I- 2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory

Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 – Volume I 2011

Summary

GlobalData, the industry analysis specialist, has released its new report, "Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 – Volume I 2011". The report is an essential source of information and analysis on the global gastric cancer therapeutics market. The report provides comprehensive information on gastric cancer, highlighting the treatment guidelines. It identifies and analyses the key trends shaping and driving the global gastric cancer therapeutics market. It analyses the treatment usage patterns in the global gastric cancer therapeutics market. The report also provides insights into the competitive landscape and the emerging players expected to significantly alter the positions of the existing market leaders. The report provides valuable insights into the pipeline products within the global gastric cancer sector. It quantifies the unmet need in the global gastric cancer therapeutics market as well as in the individual markets such as the US and the top five countries in Europe, highlighting the opportunity for
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Endoscopy Identified as Safe and Effective Method in Treating Common Complication of Gastric Bypass Surgery
2. Gastric Banding Reverses Impact of Type 2 Diabetes
3. EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study
4. Mayo Clinic Discovery May Help Diabetic Gastric Problem
5. RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments
6. FDA Provides 510k Clearance for BARRX Medicals HALO90 Ablation Catheter for the Treatment of Radiation Proctitis and Gastric Antral Vascular Ectasia (GAVE)
7. FDA Approved VIMOVO(TM) for Arthritis Patients At Risk of Developing NSAID-Associated Gastric Ulcers
8. While Ethicon Endo-Surgery and Allergan Remain Front-Runners in the $41 Million Gastric Band Market, Other Competitors Battle for Third Place, According to Millennium Research Group
9. The Spatz Adjustable Balloon System® for Weight Loss Becomes the First Intragastric Balloon to Receive Regulatory Approval for 1 Year Implantation Time
10. Mersana Therapeutics Initiates Phase 1b Extension Study of XMT-1001 in Gastric Cancer and Non-Small Cell Lung Cancer
11. Reportlinker Adds Gastric Cancer - Global Drug Forecasts and Treatment Analysis to 2020 - Volume I 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... -- Endo International plc (NASDAQ: ENDP ) ... $719 million, an increase of 1 percent compared to ... net income of $21 million in the second quarter ... the second quarter of 2013.  As detailed in the ... three months ended June 30, 2014 increased by 4 percent ...
(Date:7/31/2014)... Pa. , July 31, 2014 ... AUXL ), a specialty biopharmaceutical company, today announced ... regulatory milestone payment from its partner Asahi Kasei ... because of the successful submission of a regulatory ... Agency (PMDA) for XIAFLEX ® (collagenase clostridium ...
(Date:7/30/2014)... , July 30, 2014 Advanced Photonix ® ... (ending June 27, 2014) financial results on Monday, August 11, ... released after the close of the market and the Company ... results at 4:30 p.m. EDT on the same day. ... (CEO and Director), Rob Risser (COO and ...
Breaking Medicine Technology:Endo Reports Second Quarter Financial Results 2Endo Reports Second Quarter Financial Results 3Endo Reports Second Quarter Financial Results 4Endo Reports Second Quarter Financial Results 5Endo Reports Second Quarter Financial Results 6Endo Reports Second Quarter Financial Results 7Endo Reports Second Quarter Financial Results 8Endo Reports Second Quarter Financial Results 9Endo Reports Second Quarter Financial Results 10Endo Reports Second Quarter Financial Results 11Endo Reports Second Quarter Financial Results 12Endo Reports Second Quarter Financial Results 13Endo Reports Second Quarter Financial Results 14Endo Reports Second Quarter Financial Results 15Endo Reports Second Quarter Financial Results 16Endo Reports Second Quarter Financial Results 17Endo Reports Second Quarter Financial Results 18Endo Reports Second Quarter Financial Results 19Endo Reports Second Quarter Financial Results 20Endo Reports Second Quarter Financial Results 21Endo Reports Second Quarter Financial Results 22Endo Reports Second Quarter Financial Results 23Endo Reports Second Quarter Financial Results 24Endo Reports Second Quarter Financial Results 25Endo Reports Second Quarter Financial Results 26Endo Reports Second Quarter Financial Results 27Endo Reports Second Quarter Financial Results 28Endo Reports Second Quarter Financial Results 29Endo Reports Second Quarter Financial Results 30Endo Reports Second Quarter Financial Results 31Endo Reports Second Quarter Financial Results 32Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5
... Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced ... Healthcare Conference on Friday, September 17, 2010 at 8:35 a.m. ... the Four Seasons in Boston.  Steve Worland, Ph.D., President and ... Anadys and its clinical development programs. Dr. Worland ...
... SYK ) announced that it will host a ... Eastern Time, to discuss the Company,s operating results for the ... Operating results for the quarter ended September 30, 2010 will ... participate in the conference call dial 866-270-6057(domestic) or ...
Cached Medicine Technology:Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences 2Stryker to Host Conference Call on October 19, 2010 2
(Date:7/31/2014)... India (PRWEB) July 31, 2014 ... Marketing Company, has introduced a new service named ... , Ethane Web Technologies has designed the service ... of clients and Java Development service being provided ... the company a confidence to promise outstanding Java ...
(Date:7/31/2014)... human body contains a unique protein that has the unusual ... - it must therefore be continually recreated and is no ... including the dissolving of coagulated blood. If you get a ... a clot has accumulated in a blood vessel, and therefore ... in general and for helping people with a blood clot ...
(Date:7/31/2014)... 2014 Healthinsurancefacts.org has released a ... insurance plans by comparing quotes. , In order ... should consider comparing quotes. They can do this by ... simple questionnaire. , Clients should do proper research ... health insurance policies, and each of them can be ...
(Date:7/31/2014)... July 31, 2014 The National ... event in New York on Thursday, August 7, from ... , Featuring keynotes by State Senator Diane J. ... the event will include lunch and in-depth discussions on ... the work NCIA is doing federally to advance a ...
(Date:7/31/2014)... Beverly Hills, CA (PRWEB) July 31, 2014 ... president George W. Bush recently underwent partial knee replacement surgery ... right knee less than two months earlier. The story also ... between the procedures and hopes to be back on the ... replacement surgery highlights the benefits of partial knee replacement. ...
Breaking Medicine News(10 mins):Health News:Ethane Web Technologies Announces Java Development Service at Pocket Friendly Cost 2Health News:Breakthrough in understanding of important blood protein 2Health News:Breakthrough in understanding of important blood protein 3Health News:Comparing Health Insurance Quotes Can Help Clients Find Affordable Plans 2Health News:THURSDAY, AUG 7: First-Ever National Cannabis Industry Association Event in New York Will Feature Senator Savino, Assemblyman Katz, & Industry Leaders 2Health News:George W. Bush’s Surgery Highlights the Benefits of Partial Knee Replacement 2
... Kay Warren and Other Leaders ... Church-Based Strategy, LAKE FOREST, Calif., Nov. 29 Dr. Rick ... & The Church by,challenging attendees on the desperate need for leaders ... have AIDS?, -- but that is the,wrong question; rather, we should ...
... for filing the New,Drug Application (NDA) for the use of lacosamide ... ... UCB announced today that the U.S. Food,and Drug Administration (FDA) has ... lacosamide in the treatment of diabetic,neuropathic pain. The application relates to ...
... Inc. (Nasdaq: MITI ) and MedImmune, Inc. today ... trial of MT103 in patients with late-,stage non-Hodgkin,s lymphoma ... the American Society of Hematology (ASH) on December 9 ... recombinant T-cell,engaging antibody, or BiTE(R) antibody, targeting the CD19 ...
... Nov. 29 MedCath Corporation,(Nasdaq: MDTH ) announced ... BMO Capital Markets 2007 Focus on Healthcare Conference,held Dec. ... in New York., MedCath,s senior management will give ... ET. The presentation will be web cast live over ...
... November 29 InSightec Ltd. today,reported that it has ... its existing investors: Elbit Imaging Ltd. (Nasdaq: EMITF ... Electric Company,(NYSE: GE ), MediTech Advisors LLC ("MTA"), ... and managers of the company., The investment will ...
... ... HOOFDDORP, The Netherlands, November 29 CEVA Group Plc,released its Quarter ... - First presentation of results following the EGL acquisition on ... million in Q3 2006, - Adjusted EBITDA improved to EUR93.1million ...
Cached Medicine News:Health News:Third Annual Saddleback Global Summit on AIDS & The Church Focuses on Cooperative Leadership: 2Health News:Third Annual Saddleback Global Summit on AIDS & The Church Focuses on Cooperative Leadership: 3Health News:UCB Announces FDA Filing for lacosamide in the Treatment of Diabetic Neuropathic Pain 2Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 2Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 3Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 4Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 5Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 6Health News:InSightec Ltd. Announces US$30 Million Investment Round 2Health News:InSightec Ltd. Announces US$30 Million Investment Round 3Health News:CEVA Group Plc Reports Quarter 3, 2007 Results 2Health News:CEVA Group Plc Reports Quarter 3, 2007 Results 3Health News:CEVA Group Plc Reports Quarter 3, 2007 Results 4
... delicate urethral tissues. The gentle, ... provide nearly friction-free movement, without ... to maintain sterility. You simply ... own sterile water, avoiding contamination ...
The Antibacterial Personal Catheter® features a unique silicone composition that provides an antibacterial coated soft outer layer of silicone combined with a firm inner layer....
The Antibacterial Personal Catheter® features a unique silicone composition that provides an antibacterial coated soft outer layer of silicone combined with a firm inner layer....
... Rochester Medical's line of ... intermittent catheters you would ... four product configurations - ... antibacterial hydro - are ...
Medicine Products: